Ningbo David Medical Device Co., Ltd. (300314.SZ)
CNY 11.72
(2.27%)
CNY 11.72
(2.27%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 210.61 Million CNY | 8.9% |
| 2022 | 193.39 Million CNY | 16.95% |
| 2021 | 165.36 Million CNY | -1.93% |
| 2020 | 168.61 Million CNY | 23.73% |
| 2019 | 136.27 Million CNY | 46.32% |
| 2018 | 93.13 Million CNY | 4.62% |
| 2017 | 89.02 Million CNY | -1.62% |
| 2016 | 90.48 Million CNY | 64.9% |
| 2015 | 54.87 Million CNY | 10.22% |
| 2014 | 49.78 Million CNY | 7.34% |
| 2013 | 46.37 Million CNY | -18.77% |
| 2012 | 57.09 Million CNY | -48.78% |
| 2011 | 111.47 Million CNY | -11.95% |
| 2010 | 126.61 Million CNY | 0.66% |
| 2009 | 125.78 Million CNY | 14.93% |
| 2008 | 109.44 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 196.74 Million CNY | 20.32% |
| 2024 Q3 | 164.03 Million CNY | -16.63% |
| 2024 Q1 | 163.52 Million CNY | -22.36% |
| 2023 Q2 | 167 Million CNY | -3.92% |
| 2023 Q4 | 210.61 Million CNY | 20.27% |
| 2023 FY | 210.61 Million CNY | 8.9% |
| 2023 Q3 | 175.11 Million CNY | 4.85% |
| 2023 Q1 | 173.81 Million CNY | -10.12% |
| 2022 Q4 | 193.39 Million CNY | 14.55% |
| 2022 Q3 | 168.83 Million CNY | 10.61% |
| 2022 FY | 193.39 Million CNY | 16.95% |
| 2022 Q1 | 142.27 Million CNY | -13.96% |
| 2022 Q2 | 152.63 Million CNY | 7.29% |
| 2021 Q4 | 165.36 Million CNY | 29.66% |
| 2021 FY | 165.36 Million CNY | -1.93% |
| 2021 Q2 | 110.44 Million CNY | -3.81% |
| 2021 Q1 | 114.82 Million CNY | -31.9% |
| 2021 Q3 | 127.53 Million CNY | 15.47% |
| 2020 Q3 | 117.85 Million CNY | 5.65% |
| 2020 Q1 | 99.12 Million CNY | -27.27% |
| 2020 Q2 | 111.55 Million CNY | 12.55% |
| 2020 FY | 168.61 Million CNY | 23.73% |
| 2020 Q4 | 168.61 Million CNY | 43.07% |
| 2019 Q4 | 136.27 Million CNY | 45.84% |
| 2019 Q2 | 76.04 Million CNY | 7.04% |
| 2019 Q1 | 71.03 Million CNY | -23.73% |
| 2019 FY | 136.27 Million CNY | 46.32% |
| 2019 Q3 | 93.44 Million CNY | 22.89% |
| 2018 Q4 | 93.13 Million CNY | 32.87% |
| 2018 Q3 | 70.09 Million CNY | 2.87% |
| 2018 Q2 | 68.13 Million CNY | -4.69% |
| 2018 Q1 | 71.49 Million CNY | -19.69% |
| 2018 FY | 93.13 Million CNY | 4.62% |
| 2017 Q3 | 70.1 Million CNY | 9.72% |
| 2017 Q4 | 89.02 Million CNY | 26.99% |
| 2017 Q2 | 63.89 Million CNY | -8.15% |
| 2017 Q1 | 69.56 Million CNY | -23.12% |
| 2017 FY | 89.02 Million CNY | -1.62% |
| 2016 Q3 | 55.47 Million CNY | 1.54% |
| 2016 FY | 90.48 Million CNY | 64.9% |
| 2016 Q2 | 54.63 Million CNY | 4.35% |
| 2016 Q1 | 52.35 Million CNY | -4.58% |
| 2016 Q4 | 90.48 Million CNY | 63.1% |
| 2015 FY | 54.87 Million CNY | 10.22% |
| 2015 Q4 | 54.87 Million CNY | 20.4% |
| 2015 Q3 | 45.57 Million CNY | 3.73% |
| 2015 Q2 | 43.93 Million CNY | 4.1% |
| 2015 Q1 | 42.2 Million CNY | -15.22% |
| 2014 Q1 | 47.08 Million CNY | 1.52% |
| 2014 FY | 49.78 Million CNY | 7.34% |
| 2014 Q4 | 49.78 Million CNY | 19.58% |
| 2014 Q3 | 41.63 Million CNY | -2.26% |
| 2014 Q2 | 42.59 Million CNY | -9.52% |
| 2013 FY | 46.37 Million CNY | -18.77% |
| 2013 Q3 | 41.41 Million CNY | 7.06% |
| 2013 Q4 | 46.37 Million CNY | 11.98% |
| 2013 Q2 | 38.68 Million CNY | -11.78% |
| 2013 Q1 | 43.85 Million CNY | -23.2% |
| 2012 Q2 | 35.45 Million CNY | -61.21% |
| 2012 FY | 57.09 Million CNY | -48.78% |
| 2012 Q4 | 57.09 Million CNY | 14.33% |
| 2012 Q3 | 49.94 Million CNY | 40.85% |
| 2012 Q1 | 91.41 Million CNY | -18.0% |
| 2011 FY | 111.47 Million CNY | -11.95% |
| 2011 Q4 | 111.47 Million CNY | 5.79% |
| 2011 Q3 | 105.38 Million CNY | 0.0% |
| 2010 FY | 126.61 Million CNY | 0.66% |
| 2009 FY | 125.78 Million CNY | 14.93% |
| 2008 FY | 109.44 Million CNY | 0.0% |